Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring.

Poongothai VenkatachalapathyKarthik Kumar Dos Alagarswamy MohandossMurali Munisamy Sellapan Mohan

Published in: Current diabetes reviews (2024)

The monotherapy group of SGLT2 inhibitors demonstrated glucose-lowering effects with reduced glycemic variability. Hence, optimum glycemic control is associated with decreased glycemic variability.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
skeletal muscle
open label
metabolic syndrome
study protocol